Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years

[Ras]

Pfizer's Set to Make $131 Billion in COVID Sales in 2 Years. Is the Stock a Buy? | The Motley Fool

Despite some risks, there's a pretty good case to be made for the big pharma stock.

www.fool.com

Just in time:

Pfizer set to lose ‘billions of dollars’ as drug patents expire​

Pfizer set to lose ‘billions of dollars’ as drug patents expire

Pharma giant reports worse-than-expected fourth-quarter results on weak Viagra sales

www.irishtimes.com

Spoiler

You don't have permission to view the spoiler content. Log in or register now.

 

[Apollo]

@Ras

I have some long term call options on BioNTech, it was the easiest trade ever.